[go: up one dir, main page]

AU2001227526A1 - Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells - Google Patents

Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells

Info

Publication number
AU2001227526A1
AU2001227526A1 AU2001227526A AU2752601A AU2001227526A1 AU 2001227526 A1 AU2001227526 A1 AU 2001227526A1 AU 2001227526 A AU2001227526 A AU 2001227526A AU 2752601 A AU2752601 A AU 2752601A AU 2001227526 A1 AU2001227526 A1 AU 2001227526A1
Authority
AU
Australia
Prior art keywords
polypeptides
vectors
cells
nucleic acids
tissue derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001227526A
Inventor
Stanton Dotson
Xiao-Jun Ma
Deborah Phippard
Geetha Vasanthakamur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Publication of AU2001227526A1 publication Critical patent/AU2001227526A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001227526A 2000-01-18 2001-01-18 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells Abandoned AU2001227526A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17652300P 2000-01-18 2000-01-18
US60176523 2000-01-18
PCT/US2001/000016 WO2001053531A2 (en) 2000-01-18 2001-01-18 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells

Publications (1)

Publication Number Publication Date
AU2001227526A1 true AU2001227526A1 (en) 2001-07-31

Family

ID=22644690

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001227526A Abandoned AU2001227526A1 (en) 2000-01-18 2001-01-18 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells

Country Status (3)

Country Link
US (1) US20020119452A1 (en)
AU (1) AU2001227526A1 (en)
WO (1) WO2001053531A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0112339A (en) * 2000-07-13 2003-04-15 Akzo Nobel Nv Polynucleotide encoding a polypeptide, recombinant expression vector, polypeptide, pharmaceutical composition, use of cell polypeptide, use of a dna or expression vector, or cell or polypeptide, method for identifying tolerogenic peptides, method for formulation of a pharmaceutical composition, use of a peptide, diagnostic composition, and diagnostic method and test kit for detecting activated autoreactive t cells
CA2443147A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
AU2002348268A1 (en) * 2001-12-03 2003-06-17 Bristol-Myers Squibb Company Polynucleotides and polypeptides associated with the development of osteoarthritis
AU2003289716A1 (en) * 2002-09-12 2004-04-30 Incyte Corporation Molecules for diagnostics and therapeutics
WO2004024892A2 (en) * 2002-09-12 2004-03-25 Chondrogene Inc. Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis
FR2862314A1 (en) * 2003-11-13 2005-05-20 Exonhit Therapeutics Sa Method for diagnosing encephalopathy, or the risk of developing it, useful particularly in screening cattle for bovine spongiform encephalopathy, based on detecting specific nucleic acid markers
US8224579B2 (en) * 2005-06-17 2012-07-17 The Brigham And Women's Hospital, Inc. Method of diagnosing osteoarthritis
US7812125B2 (en) * 2007-03-27 2010-10-12 Anamar Medical Ab Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
US20080241945A1 (en) * 2007-03-27 2008-10-02 Pilar Lorenzo Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
JP5603232B2 (en) 2007-05-01 2014-10-08 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Methods and compositions for diagnosing osteoarthritis in cats
KR101666228B1 (en) 2007-09-28 2016-10-13 인트렉손 코포레이션 Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498827B1 (en) * 1989-11-02 2001-08-01 DictyTech Pty Limited Improved plasmid vectors for cellular slime moulds of the genus dictyostelium
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
GB9726539D0 (en) * 1997-12-16 1998-02-11 Univ Dundee Polypeptides, polynucleotides and uses thereof
AU2575000A (en) * 1999-02-19 2000-09-04 Terumo Kabushiki Kaisha Collagen-binding physiologically active polypeptide

Also Published As

Publication number Publication date
US20020119452A1 (en) 2002-08-29
WO2001053531A3 (en) 2001-12-20
WO2001053531A2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
AU4095999A (en) Cell cycle genes, proteins and uses thereof
AU2001269709A1 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU4498500A (en) Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU6277799A (en) Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and usesthereof
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU8146601A (en) AKT nucleic acids, polypeptides, and uses thereof
WO2002016439A8 (en) Novel nucleic acids and polypeptides
AU2001227526A1 (en) Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells
AU2389200A (en) Cell cycle nucleic acids, polypeptides and uses thereof
AU2001264955A1 (en) Human cyslt2 nucleic acids, polypeptides, and uses thereof
AU5617200A (en) Nodavirus-based dna expression vector and uses thereof
AU2002365189A1 (en) P85-alpha nucleic acids, polypeptides and related methods